Cargando…
Endolysosomal TRPMLs in Cancer
Lysosomes, the degradative endpoints and sophisticated cellular signaling hubs, are emerging as intracellular Ca(2+) stores that govern multiple cellular processes. Dys-homeostasis of lysosomal Ca(2+) is intimately associated with a variety of human diseases including cancer. Recent studies have sug...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825278/ https://www.ncbi.nlm.nih.gov/pubmed/33419007 http://dx.doi.org/10.3390/biom11010065 |
_version_ | 1783640270000095232 |
---|---|
author | Xu, Mengnan Dong, Xian-Ping |
author_facet | Xu, Mengnan Dong, Xian-Ping |
author_sort | Xu, Mengnan |
collection | PubMed |
description | Lysosomes, the degradative endpoints and sophisticated cellular signaling hubs, are emerging as intracellular Ca(2+) stores that govern multiple cellular processes. Dys-homeostasis of lysosomal Ca(2+) is intimately associated with a variety of human diseases including cancer. Recent studies have suggested that the Ca(2+)-permeable channels Transient Receptor Potential (TRP) Mucolipins (TRPMLs, TRPML1-3) integrate multiple processes of cell growth, division and metabolism. Dysregulation of TRPMLs activity has been implicated in cancer development. In this review, we provide a summary of the latest development of TRPMLs in cancer. The expression of TRPMLs in cancer, TRPMLs in cancer cell nutrient sensing, TRPMLs-mediated lysosomal exocytosis in cancer development, TRPMLs in TFEB-mediated gene transcription of cancer cells, TRPMLs in bacteria-related cancer development and TRPMLs-regulated antitumor immunity are discussed. We hope to guide readers toward a more in-depth discussion of the importance of lysosomal TRPMLs in cancer progression and other human diseases. |
format | Online Article Text |
id | pubmed-7825278 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78252782021-01-24 Endolysosomal TRPMLs in Cancer Xu, Mengnan Dong, Xian-Ping Biomolecules Review Lysosomes, the degradative endpoints and sophisticated cellular signaling hubs, are emerging as intracellular Ca(2+) stores that govern multiple cellular processes. Dys-homeostasis of lysosomal Ca(2+) is intimately associated with a variety of human diseases including cancer. Recent studies have suggested that the Ca(2+)-permeable channels Transient Receptor Potential (TRP) Mucolipins (TRPMLs, TRPML1-3) integrate multiple processes of cell growth, division and metabolism. Dysregulation of TRPMLs activity has been implicated in cancer development. In this review, we provide a summary of the latest development of TRPMLs in cancer. The expression of TRPMLs in cancer, TRPMLs in cancer cell nutrient sensing, TRPMLs-mediated lysosomal exocytosis in cancer development, TRPMLs in TFEB-mediated gene transcription of cancer cells, TRPMLs in bacteria-related cancer development and TRPMLs-regulated antitumor immunity are discussed. We hope to guide readers toward a more in-depth discussion of the importance of lysosomal TRPMLs in cancer progression and other human diseases. MDPI 2021-01-06 /pmc/articles/PMC7825278/ /pubmed/33419007 http://dx.doi.org/10.3390/biom11010065 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Xu, Mengnan Dong, Xian-Ping Endolysosomal TRPMLs in Cancer |
title | Endolysosomal TRPMLs in Cancer |
title_full | Endolysosomal TRPMLs in Cancer |
title_fullStr | Endolysosomal TRPMLs in Cancer |
title_full_unstemmed | Endolysosomal TRPMLs in Cancer |
title_short | Endolysosomal TRPMLs in Cancer |
title_sort | endolysosomal trpmls in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825278/ https://www.ncbi.nlm.nih.gov/pubmed/33419007 http://dx.doi.org/10.3390/biom11010065 |
work_keys_str_mv | AT xumengnan endolysosomaltrpmlsincancer AT dongxianping endolysosomaltrpmlsincancer |